Comparison of influenza virus yields and apoptosis-induction in an adherent and a suspension MDCK cell line

Vaccine

Volumn 31, Issue 48, 2013, Pages 5693-5699

  Peschel, B ^a   Frentzel, S ^b   Laske, T ^b   Genzel, Y ^a   Reichl, U ^a,b  

^a MAX PLANCK INSTITUTE FOR DYNAMICS OF COMPLEX TECHNICAL SYSTEMS   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Flow cytometry; Influenza; MDCK suspension cells; Medium exchange; Trypsin activity; Vaccine

Indexed keywords

CELL ADHESION MOLECULE; VIRUS PROTEIN;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANOIKIS; APOPTOSIS; ARTICLE; BIOREACTOR; CELL LINE; CELL SPECIFICITY; CELL SURVIVAL; CELL SUSPENSION; CONTROLLED STUDY; DILUTION; FLOW CYTOMETRY; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA VIRUS; MDCK CELL; NONHUMAN; PRIORITY JOURNAL; VIRION;

1:2 DILUTION AT TOI; 1:2DIL; 50% TISSUE CULTURE INFECTIVE DOSE; A/PR/8; A/PUERTO RICO/8/34; CARCINOEMBRYONIC ANTIGEN-RELATED CELL ADHESION MOLECULE 6; CEACAM6; EMA; EUROPEAN MEDICINES AGENCY; FDA; FITC; FLOW CYTOMETRY; FLUORESCEIN ISOTHIOCYANATE; FOOD AND DRUG ADMINISTRATION; GLASGOW MINIMUM ESSENTIAL MEDIUM; GMEM; HA; HAEMAGGLUTININ; HOURS POST INFECTION; HPI; INFLUENZA; MAD; MADIN-DARBY CANINE KIDNEY; MDCK; MDCK SUSPENSION CELLS; MEDIAN OF ABSOLUTE DEVIATION; MEDIUM EXCHANGE; MOI; MULTIPLICITY OF INFECTION; PHOSPHATIDYLINOSITIDE 3-KINASE; PI3K; TCID(50); TDT DUTP NICK END LABELLING; TIME OF INFECTION; TOI; TRYPSIN ACTIVITY; TUNEL; VACCINE; W/OME; WITH MEDIUM EXCHANGE; WITHOUT MEDIUM EXCHANGE; WME;

ANIMALS; APOPTOSIS; CELL ADHESION; CELL SURVIVAL; CELLS, IMMOBILIZED; DOGS; INFLUENZA A VIRUS, H1N1 SUBTYPE; MADIN DARBY CANINE KIDNEY CELLS; VIRAL LOAD; VIRUS CULTIVATION;

EID: 84886949384     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.09.051     Document Type: Article

References (34)

1. Montomoli E., Khadang B., Piccirella S., Trombetta C., Mennitto E., Manini I., et al. Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production. Expert Rev Vaccines 2012, 11(May (5)):587-594.
2. Genzel Y., Reichl U. Continuous cell lines as a production system for influenza vaccines. Expert Rev Vaccines 2009, 8(December (12)):1681-1692.
3. Genzel Y., Behrendt I., Rodig J., Rapp E., Kueppers C., Kochanek S., et al. CAP, a new human suspension cell line for influenza virus production. Appl Microbiol Biotechnol 2013, 97(January (1)):111-122.
4. Le Ru A., Jacob D., Transfiguracion J., Ansorge S., Henry O., Kamen A.A. Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing. Vaccine 2010, 28(21):3661-3671. May 7.
5. Feng S.Z., Jiao P.R., Qi W.B., Fan H.Y., Liao M. Development and strategies of cell-culture technology for influenza vaccine. Appl Microbiol Biotechnol 2011, 89(February (4)):893-902.
6. Vivalis Ltd. WO2006108846-A1 2006.
7. Gaush C.R., Smith T.F. Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl Microbiol 1968, 16(April (4)):588-594.
8. Novartis A.G. WO2008032219-A2 2008.
9. Chu C., Lugovtsev V., Golding H., Betenbaugh M., Shiloach J. Conversion of MDCK cell line to suspension culture by transfecting with human siat7e gene and its application for influenza virus production. Proc Natl Acad Sci USA 2009, 106(35):14802-14807. September 1.
10. Chu C., Lugovtsev V., Lewis A., Betenbaugh M., Shiloach J. Production and antigenic properties of influenza virus from suspension MDCK-siat7e cells in a bench-scale bioreactor. Vaccine 2010, 28(44):7193-7201. October 18.
11. Tsutsumi R., Fujisaki S., Shozushima M., Saito K., Sato S. Anoikis-resistant MDCK cells carrying susceptibilities to TNF-alpha and verotoxin that are suitable for influenza virus cultivation. Cytotechnology 2006, 52(October (2)):71-85.
12. van Wielink R., Kant-Eenbergen H.C., Harmsen M.M., Martens D.E., Wijffels R.H., Coco-Martin J.M. Adaptation of a Madin-Darby canine kidney cell line to suspension growth in serum-free media and comparison of its ability to produce avian influenza virus to Vero and BHK21 cell lines. J Virol Methods 2011, 171(January (1)):53-60.
13. Lohr V., Genzel Y., Behrendt I., Scharfenberg K., Reichl U. A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor. Vaccine 2010, 28(38):6256-6264. August 31.
14. Frisch S.M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994, 124(February (4)):619-626.
15. Zhong X., Rescorla F.J. Cell surface adhesion molecules and adhesion-initiated signaling: understanding of anoikis resistance mechanisms and therapeutic opportunities. Cell Signal 2012, 24(February (2)):393-401.
16. Mitra S.K., Schlaepfer D.D. Integrin-regulated FAK-Src signaling in normal and cancer cells. Current opinion in cell biology 2006, 18(October (5)):516-523.
17. Herold S., Ludwig S., Pleschka S., Wolff T. Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury. J Leukoc Biol 2012, 92(July (1)):75-82.
18. Isken B., Genzel Y., Reichl U. Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants. Vaccine 2012, 30(35):5253-5261. July 27.
19. Schulze-Horsel J., Schulze M., Agalaridis G., Genzel Y., Reichl U. Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-flow cytometry and mathematical modeling. Vaccine 2009, 27(20):2712-2722. May 5.
20. Bock A., Sann H., Schulze-Horsel J., Genzel Y., Reichl U., Mohler L. Growth behavior of number distributed adherent MDCK cells for optimization in microcarrier cultures. Biotechnol Prog 2009, 25(November/December (6)):1717-1731.
21. Kalbfuss B., Knochlein A., Krober T., Reichl U. Monitoring influenza virus content in vaccine production: precise assays for the quantitation of hemagglutination and neuraminidase activity. Biologicals 2008, 36(May (3)):145-161.
22. Genzel Y., Reichl U. Vaccine production-state of the art and future needs in upstream processing. Animal cell biotechnology: methods and protocols 2007, 457-473. Humana Press Inc, Totowa, NJ. R. Poertner (Ed.).
23. Chan C.Y., Tambyah P.A. Preflucel(R): a Vero-cell culture-derived trivalent influenza vaccine. Expert Rev Vaccines 2012, 11(July (7)):759-773.
24. Aggarwal K., Jing F., Maranga L., Liu J. Bioprocess optimization for cell culture based influenza vaccine production. Vaccine 2011, 29(17):3320-3328. April 12.
25. Pohlscheidt M., Langer U., Minuth T., Bodeker B., Apeler H., Horlein H.D., et al. Development and optimisation of a procedure for the production of Parapoxvirus ovis by large-scale microcarrier cell culture in a non-animal, non-human and non-plant-derived medium. Vaccine 2008, 26(12):1552-1565. March 17.
26. Petiot E., Jacob D., Lanthier S., Lohr V., Ansorge S., Kamen A.A. Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture. BMC Biotechnol 2011, 11:84.
27. Emma P., Kamen A. Real-time monitoring of influenza virus production kinetics in HEK293 cell cultures. Biotechnol Progr 2013, 29(January/February (1)):275-284.
28. Pau M.G., Ophorst C., Koldijk M.H., Schouten G., Mehtali M., Uytdehaag F. The human cell line PER. C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine 2001, 19(17-19):2716-2721. March 21.
29. Lohr V., Genzel Y., Jordan I., Katinger D., Mahr S., Sandig V., et al. Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells. BMC Biotechnol 2012, 12:79.
30. Genzel Y., Dietzsch C., Rapp E., Schwarzer J., Reichl U. MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation. Appl Microbiol Biotechnol 2010, 88(September (2)):461-475.
31. Hu A.Y.-C., Weng T.-C., Tseng Y.-F., Chen Y.-S., Wu C.-H., Hsiao S., et al. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines. Vaccine 2008, 26(45):5736-5740.
32. Gaur P., Ranjan P., Sharma S., Patel J.R., Bowzard J.B., Rahman S.K., et al. Influenza A virus neuraminidase protein enhances cell survival through interaction with carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) protein. J Biol Chem 2012, 287(18):15109-15117. April 27.
33. Coombs K.M., Berard A., Xu W., Krokhin O., Meng X., Cortens J.P., et al. Quantitative proteomic analyses of influenza virus-infected cultured human lung cells. J Virol 2010, 84(October (20)):10888-10906.
34. Heldt F.S., Frensing T., Reichl U. Modeling the intracellular dynamics of influenza virus replication to understand the control of viral RNA synthesis. J Virol 2012, 86(August (15)):7806-7817.